{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-092690","form_type":"8-K","ticker":"ADIL","cik":"0001513525","company_name":"ADIAL PHARMACEUTICALS, INC.","filed_at":"2026-08-21T21:17:59+00:00","discovered_at":"2026-08-21T21:20:00.356919+00:00","generated_at":"2026-08-21T21:20:04.093130+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Adial receives Nasdaq delisting notice for equity shortfall","bullets":["On Aug 18, 2026, Nasdaq said stockholders' equity fell below $2.5M minimum for continued listing.","Company also fails alternative $35M market value or $500K net income standards.","Must submit compliance plan by Oct 2, 2026; intends to convert Series A preferred stock at 2026 annual meeting.","If accepted, Nasdaq may grant up to 180-day extension; delisting stay via hearing possible."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-092690","json":"https://secwatch.observer/filing/0001213900-26-092690.json","markdown":"https://secwatch.observer/filing/0001213900-26-092690.md","text":"https://secwatch.observer/filing/0001213900-26-092690.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1513525/000121390026092690/0001213900-26-092690-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1513525/000121390026092690/ea0302970-8k_adial.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-21T21:20:04.093130+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}